Weight loss drug before prostate cancer surgery pilot study
Treatments studied
Part of Cancer, Hormones & metabolism, Kidney & urinary clinical trials.
This study tests if taking tirzepatide (a weight loss medicine) before prostate removal surgery is safe and helpful for overweight men with intermediate-risk prostate cancer. It aims to see if losing weight can improve surgery outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 30 and 75 years old
- You have been diagnosed with prostate cancer that is intermediate-risk and has not spread
- You are planning to have surgery to remove your prostate
- You have diabetes and are overweight (BMI 27 or higher, or waist over 40 inches) OR you have a BMI of 30 or higher, OR a BMI of 27 or higher with a weight-related condition (like high blood pressure, high cholesterol, sleep apnea, or heart disease)
- You have not taken weight loss medicine, had weight loss surgery, or lost more than 11 pounds in the last 3 months
- You do not have severe kidney, liver, pancreas, stomach, or psychiatric conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if tirzepatide (a weight loss drug) can help women and men with early-stage hormone receptor-positive breast cancer who are overweight or obese. The goal is to see if losing weight can improve outcomes after completing their initial breast cancer treatment.
This study tests whether a weight-loss medication can affect breast cancer tumors before surgery. It is for postmenopausal women with early-stage, hormone-positive breast cancer who are overweight or obese.
This trial tests whether tirzepatide, a weekly injection that helps with weight loss and blood sugar control, can improve outcomes for women with obesity and early-stage endometrial cancer (or precancerous changes) who are scheduled for surgery. The goal is to see if taking this medication before surgery can help shrink the cancer or improve surgical results.
This trial tests if the weight-loss drug tirzepatide can help people with obesity-related endometrial cancer before their hysterectomy. It may improve surgical outcomes and overall health.
This trial is testing two ways to prepare for weight-loss surgery: a medication called tirzepatide (Mounjaro) or a keto diet. Both are compared to standard care to see which helps improve health before the operation.
This study tests a medication called tirzepatide (a daily injection) to help people who haven't lost enough weight after weight-loss surgery. If you fit the criteria, the medication may help you lose more weight healthily.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.